ScholarLens Back to search
2011•Clinical Medical EngineeringRequires access

Efficacy of Entecavir in Treatment of Hepatitis B Cirrhosis

Ming Liang

Open publisher page 0 citations

Abstract

Objective To explore the clinical efficacy of entecavir in the treatment of decompensated hepatitis B patients with cirrhosis. Methods Hepatitis B patients with cirrhosis in the Hepatobiliary Surgery Department of our hospital were divided into experimental group and control group. The control group received conventional liver protection treatment, while the experimental group were treated with entecavir based on the conventional lliver protection treatment. Results The patients' ALB, ALT, TBiL, PTA, Child-Pugh points, HBV DNA and other indicators after treatment were significantly better than those before treatment (P 0.05); the above indices in the experimental group were significantly better than those in the control group (P 0.05). Conclusion Entecavir treatment of hepatitis B patients with cirrhosis can improve patients' quality of life and prognosis.

About this research paper

What this paper is about

Objective To explore the clinical efficacy of entecavir in the treatment of decompensated hepatitis B patients with cirrhosis. Methods Hepatitis B patients with cirrhosis in the Hepatobiliary Surgery Department of our hospital were divided into experimental group and control group. The control group received conventional liver protection treatment, while the experimental group were treated with entecavir based on the conventional lliver protection treatment. Results The patients' ALB, ALT, TBiL, PTA, Child-Pugh points, HBV DNA and other indicators after treatment were significantly better than those before treatment (P 0.05); the above indices in the experimental group were significantly better than those in the control group (P 0.05). Conclusion Entecavir treatment of hepatitis B patients with cirrhosis can improve patients' quality of life and prognosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the clinical efficacy of entecavir in the treatment of decompensated hepatitis B patients with cirrhosis. Methods Hepatitis B patients with cirrhosis in the Hepatobiliary Surgery Department of our hospital were divided into experimental group and control group. The control group received conventional liver protection treatment, while the experimental group were treated with entecavir based on the conventional lliver protection treatment. Results The patients' ALB, ALT, TBiL, PTA, Child-Pugh points, HBV DNA and other indicators after treatment were significantly better than those before treatment (P 0.05); the above indices in the experimental group were significantly better than those in the control group (P 0.05). Conclusion Entecavir treatment of hepatitis B patients with cirrhosis can improve patients' quality of life and prognosis.

Key concepts: Entecavir, Medicine, Cirrhosis, Gastroenterology, Internal medicine, Hepatitis B, Antiviral treatment, Hepatitis a virus

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Efficacy of Entecavir in Treatment of Hepatitis B Cirrhosis — Research Paper | ScholarLens